A new trading day began on Friday, with Voyager Therapeutics Inc (NASDAQ: VYGR) stock price up 10.51% from the previous day of trading, before settling in for the closing price of $4.09. VYGR’s price has ranged from $2.64 to $8.27 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 1.48% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -87.10%. With a float of $45.49 million, this company’s outstanding shares have now reached $55.43 million.
Voyager Therapeutics Inc (VYGR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Voyager Therapeutics Inc is 17.99%, while institutional ownership is 59.99%. The most recent insider transaction that took place on Aug 18 ’25, was worth 70,870. In this transaction Chief Medical Officer of this company sold 19,000 shares at a rate of $3.73, taking the stock ownership to the 138,914 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 19,000 for $3.72, making the entire transaction worth $70,680.
Voyager Therapeutics Inc (VYGR) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.16 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.86% during the next five years compared to 1.48% growth over the previous five years of trading.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Here are Voyager Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.85, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.73 million. That was better than the volume of 0.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.19%.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 97.91%, which indicates a significant increase from 93.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.66, while its 200-day Moving Average is $3.99. However, in the short run, Voyager Therapeutics Inc’s stock first resistance to watch stands at $4.68. Second resistance stands at $4.84. The third major resistance level sits at $5.15. If the price goes on to break the first support level at $4.21, it is likely to go to the next support level at $3.90. Assuming the price breaks the second support level, the third support level stands at $3.74.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
With a market capitalization of 250.72 million, the company has a total of 55,469K Shares Outstanding. Currently, annual sales are 80,000 K while annual income is -65,000 K. The company’s previous quarter sales were 5,200 K while its latest quarter income was -33,380 K.
